| Financial Year |
March 31 2023 |
| Monetary Funds |
488,038,164.83 |
| Held-for-trading Financial Assets |
5,838,008.26 |
| Notes Receivable |
-- |
| Accounts Receivable |
31,497,756.10 |
| Advances to Suppliers |
24,214,097.26 |
| Other Receivables |
1,387,446.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
29,206,251.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,526,159.55 |
| Total Current Assets |
581,707,883.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
272,950,963.91 |
| Under-construction Projects |
13,137,971.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
45,011,726.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
327,800.66 |
| Deferred Income Tax Assets |
50,547,432.18 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
382,224,417.13 |
| Total Assets |
963,932,300.47 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
42,436,737.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,085,476.47 |
| Taxes Payable |
3,275,950.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
7,248,212.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
192,478.07 |
| Other Current Liabilities |
10,946,021.96 |
| Sub-Total of Current Liabilities |
234,303,172.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,382,541.10 |
| Deferred Income Tax Liabilities |
41,099.16 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,423,640.26 |
| Total Liabilities |
235,726,812.42 |
| Paid-In Capital(Or Share Stock) |
422,426,880.00 |
| Capital Surplus |
23,632,226.51 |
| Surplus Reserve |
75,645,886.46 |
| LESS:Treasury Stock |
33,187,929.14 |
| Undistributed Profits |
230,034,929.31 |
| Minority Stockholder's Interest |
7,825,069.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
720,380,418.40 |
| Owner's Equity（Stockholder's Equity） |
728,205,488.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
963,932,300.47 |
